nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Estropipate—osteoporosis	0.158	0.432	CbGbCtD
Betaxolol—CYP1A2—Conjugated Estrogens—osteoporosis	0.0746	0.205	CbGbCtD
Betaxolol—CYP2D6—Cholecalciferol—osteoporosis	0.0669	0.184	CbGbCtD
Betaxolol—CYP1A2—Estradiol—osteoporosis	0.0655	0.18	CbGbCtD
Betaxolol—Chlorphenesin—CYP19A1—osteoporosis	0.00167	1	CrCbGaD
Betaxolol—Headache—Etidronic acid—osteoporosis	0.000367	0.00058	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000365	0.000577	CcSEcCtD
Betaxolol—Asthenia—Estropipate—osteoporosis	0.000364	0.000574	CcSEcCtD
Betaxolol—Visual impairment—Estradiol—osteoporosis	0.000364	0.000574	CcSEcCtD
Betaxolol—Anorexia—Pamidronate—osteoporosis	0.000363	0.000573	CcSEcCtD
Betaxolol—Chest pain—Zoledronate—osteoporosis	0.000363	0.000573	CcSEcCtD
Betaxolol—Myalgia—Zoledronate—osteoporosis	0.000363	0.000573	CcSEcCtD
Betaxolol—Arthralgia—Zoledronate—osteoporosis	0.000363	0.000573	CcSEcCtD
Betaxolol—Palpitations—Conjugated Estrogens—osteoporosis	0.000363	0.000573	CcSEcCtD
Betaxolol—Insomnia—Risedronate—osteoporosis	0.000363	0.000572	CcSEcCtD
Betaxolol—Anxiety—Zoledronate—osteoporosis	0.000362	0.000571	CcSEcCtD
Betaxolol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000361	0.00057	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000361	0.000569	CcSEcCtD
Betaxolol—Paraesthesia—Risedronate—osteoporosis	0.00036	0.000568	CcSEcCtD
Betaxolol—Pruritus—Estropipate—osteoporosis	0.000359	0.000566	CcSEcCtD
Betaxolol—Discomfort—Zoledronate—osteoporosis	0.000359	0.000566	CcSEcCtD
Betaxolol—Asthenia—Alendronate—osteoporosis	0.000359	0.000566	CcSEcCtD
Betaxolol—Hypersensitivity—Ibandronate—osteoporosis	0.000358	0.000566	CcSEcCtD
Betaxolol—Cough—Conjugated Estrogens—osteoporosis	0.000358	0.000566	CcSEcCtD
Betaxolol—Dyspnoea—Risedronate—osteoporosis	0.000357	0.000564	CcSEcCtD
Betaxolol—Hypotension—Pamidronate—osteoporosis	0.000356	0.000562	CcSEcCtD
Betaxolol—Dry mouth—Zoledronate—osteoporosis	0.000355	0.000561	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000355	0.00056	CcSEcCtD
Betaxolol—Fatigue—Ethinyl Estradiol—osteoporosis	0.000355	0.00056	CcSEcCtD
Betaxolol—Pruritus—Alendronate—osteoporosis	0.000354	0.000558	CcSEcCtD
Betaxolol—Dyspepsia—Risedronate—osteoporosis	0.000353	0.000557	CcSEcCtD
Betaxolol—Eye disorder—Estradiol—osteoporosis	0.000353	0.000557	CcSEcCtD
Betaxolol—Tinnitus—Estradiol—osteoporosis	0.000352	0.000556	CcSEcCtD
Betaxolol—Constipation—Ethinyl Estradiol—osteoporosis	0.000352	0.000555	CcSEcCtD
Betaxolol—Confusional state—Zoledronate—osteoporosis	0.000351	0.000554	CcSEcCtD
Betaxolol—Hypersensitivity—Calcitriol—osteoporosis	0.000351	0.000554	CcSEcCtD
Betaxolol—Flushing—Estradiol—osteoporosis	0.000351	0.000553	CcSEcCtD
Betaxolol—Cardiac disorder—Estradiol—osteoporosis	0.000351	0.000553	CcSEcCtD
Betaxolol—Myalgia—Conjugated Estrogens—osteoporosis	0.00035	0.000552	CcSEcCtD
Betaxolol—Arthralgia—Conjugated Estrogens—osteoporosis	0.00035	0.000552	CcSEcCtD
Betaxolol—Chest pain—Conjugated Estrogens—osteoporosis	0.00035	0.000552	CcSEcCtD
Betaxolol—Asthenia—Ibandronate—osteoporosis	0.000349	0.000551	CcSEcCtD
Betaxolol—Anxiety—Conjugated Estrogens—osteoporosis	0.000349	0.00055	CcSEcCtD
Betaxolol—Nausea—Etidronic acid—osteoporosis	0.000348	0.00055	CcSEcCtD
Betaxolol—Oedema—Zoledronate—osteoporosis	0.000348	0.000549	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000347	0.000548	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000347	0.000548	CcSEcCtD
Betaxolol—Diarrhoea—Estropipate—osteoporosis	0.000347	0.000548	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000346	0.000546	CcSEcCtD
Betaxolol—Infection—Zoledronate—osteoporosis	0.000346	0.000546	CcSEcCtD
Betaxolol—Fatigue—Risedronate—osteoporosis	0.000346	0.000546	CcSEcCtD
Betaxolol—Insomnia—Pamidronate—osteoporosis	0.000345	0.000544	CcSEcCtD
Betaxolol—Pruritus—Ibandronate—osteoporosis	0.000344	0.000543	CcSEcCtD
Betaxolol—Pain—Risedronate—osteoporosis	0.000343	0.000541	CcSEcCtD
Betaxolol—Constipation—Risedronate—osteoporosis	0.000343	0.000541	CcSEcCtD
Betaxolol—Angiopathy—Estradiol—osteoporosis	0.000343	0.000541	CcSEcCtD
Betaxolol—Shock—Zoledronate—osteoporosis	0.000343	0.000541	CcSEcCtD
Betaxolol—Paraesthesia—Pamidronate—osteoporosis	0.000342	0.00054	CcSEcCtD
Betaxolol—Diarrhoea—Alendronate—osteoporosis	0.000342	0.00054	CcSEcCtD
Betaxolol—Asthenia—Calcitriol—osteoporosis	0.000342	0.000539	CcSEcCtD
Betaxolol—Nervous system disorder—Zoledronate—osteoporosis	0.000341	0.000539	CcSEcCtD
Betaxolol—Immune system disorder—Estradiol—osteoporosis	0.000341	0.000538	CcSEcCtD
Betaxolol—Thrombocytopenia—Zoledronate—osteoporosis	0.000341	0.000538	CcSEcCtD
Betaxolol—Mediastinal disorder—Estradiol—osteoporosis	0.00034	0.000537	CcSEcCtD
Betaxolol—Dyspnoea—Pamidronate—osteoporosis	0.00034	0.000536	CcSEcCtD
Betaxolol—Tachycardia—Zoledronate—osteoporosis	0.00034	0.000536	CcSEcCtD
Betaxolol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000339	0.000535	CcSEcCtD
Betaxolol—Chills—Estradiol—osteoporosis	0.000339	0.000535	CcSEcCtD
Betaxolol—Skin disorder—Zoledronate—osteoporosis	0.000338	0.000534	CcSEcCtD
Betaxolol—Pruritus—Calcitriol—osteoporosis	0.000337	0.000532	CcSEcCtD
Betaxolol—Hyperhidrosis—Zoledronate—osteoporosis	0.000337	0.000531	CcSEcCtD
Betaxolol—Diarrhoea—Raloxifene—osteoporosis	0.000336	0.000531	CcSEcCtD
Betaxolol—Dyspepsia—Pamidronate—osteoporosis	0.000336	0.000529	CcSEcCtD
Betaxolol—Dizziness—Estropipate—osteoporosis	0.000336	0.000529	CcSEcCtD
Betaxolol—Oedema—Conjugated Estrogens—osteoporosis	0.000335	0.000529	CcSEcCtD
Betaxolol—Alopecia—Estradiol—osteoporosis	0.000334	0.000527	CcSEcCtD
Betaxolol—Infection—Conjugated Estrogens—osteoporosis	0.000333	0.000526	CcSEcCtD
Betaxolol—Diarrhoea—Ibandronate—osteoporosis	0.000333	0.000525	CcSEcCtD
Betaxolol—Anorexia—Zoledronate—osteoporosis	0.000332	0.000524	CcSEcCtD
Betaxolol—Decreased appetite—Pamidronate—osteoporosis	0.000331	0.000523	CcSEcCtD
Betaxolol—Mental disorder—Estradiol—osteoporosis	0.000331	0.000522	CcSEcCtD
Betaxolol—Dizziness—Alendronate—osteoporosis	0.00033	0.000522	CcSEcCtD
Betaxolol—Shock—Conjugated Estrogens—osteoporosis	0.00033	0.000521	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000329	0.000519	CcSEcCtD
Betaxolol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000329	0.000519	CcSEcCtD
Betaxolol—Erythema—Estradiol—osteoporosis	0.000329	0.000519	CcSEcCtD
Betaxolol—Malnutrition—Estradiol—osteoporosis	0.000329	0.000519	CcSEcCtD
Betaxolol—Fatigue—Pamidronate—osteoporosis	0.000329	0.000519	CcSEcCtD
Betaxolol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000327	0.000516	CcSEcCtD
Betaxolol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000327	0.000516	CcSEcCtD
Betaxolol—Pain—Pamidronate—osteoporosis	0.000326	0.000514	CcSEcCtD
Betaxolol—Constipation—Pamidronate—osteoporosis	0.000326	0.000514	CcSEcCtD
Betaxolol—Diarrhoea—Calcitriol—osteoporosis	0.000326	0.000514	CcSEcCtD
Betaxolol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000326	0.000514	CcSEcCtD
Betaxolol—Hypotension—Zoledronate—osteoporosis	0.000325	0.000513	CcSEcCtD
Betaxolol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000325	0.000513	CcSEcCtD
Betaxolol—Dizziness—Raloxifene—osteoporosis	0.000325	0.000513	CcSEcCtD
Betaxolol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000324	0.000511	CcSEcCtD
Betaxolol—Tension—Estradiol—osteoporosis	0.000323	0.000509	CcSEcCtD
Betaxolol—Vomiting—Estropipate—osteoporosis	0.000323	0.000509	CcSEcCtD
Betaxolol—Dysgeusia—Estradiol—osteoporosis	0.000322	0.000508	CcSEcCtD
Betaxolol—Dizziness—Ibandronate—osteoporosis	0.000322	0.000508	CcSEcCtD
Betaxolol—Rash—Estropipate—osteoporosis	0.00032	0.000505	CcSEcCtD
Betaxolol—Dermatitis—Estropipate—osteoporosis	0.00032	0.000504	CcSEcCtD
Betaxolol—Anorexia—Conjugated Estrogens—osteoporosis	0.00032	0.000504	CcSEcCtD
Betaxolol—Nervousness—Estradiol—osteoporosis	0.000319	0.000504	CcSEcCtD
Betaxolol—Urticaria—Risedronate—osteoporosis	0.000319	0.000503	CcSEcCtD
Betaxolol—Headache—Estropipate—osteoporosis	0.000318	0.000502	CcSEcCtD
Betaxolol—Vomiting—Alendronate—osteoporosis	0.000318	0.000501	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000317	0.000501	CcSEcCtD
Betaxolol—Body temperature increased—Risedronate—osteoporosis	0.000317	0.0005	CcSEcCtD
Betaxolol—Muscle spasms—Estradiol—osteoporosis	0.000316	0.000499	CcSEcCtD
Betaxolol—Rash—Alendronate—osteoporosis	0.000315	0.000497	CcSEcCtD
Betaxolol—Insomnia—Zoledronate—osteoporosis	0.000315	0.000497	CcSEcCtD
Betaxolol—Dermatitis—Alendronate—osteoporosis	0.000315	0.000497	CcSEcCtD
Betaxolol—Feeling abnormal—Pamidronate—osteoporosis	0.000314	0.000496	CcSEcCtD
Betaxolol—Hypotension—Conjugated Estrogens—osteoporosis	0.000313	0.000494	CcSEcCtD
Betaxolol—Headache—Alendronate—osteoporosis	0.000313	0.000494	CcSEcCtD
Betaxolol—Paraesthesia—Zoledronate—osteoporosis	0.000313	0.000493	CcSEcCtD
Betaxolol—Vomiting—Raloxifene—osteoporosis	0.000312	0.000493	CcSEcCtD
Betaxolol—Dyspnoea—Zoledronate—osteoporosis	0.00031	0.00049	CcSEcCtD
Betaxolol—Rash—Raloxifene—osteoporosis	0.00031	0.000489	CcSEcCtD
Betaxolol—Dermatitis—Raloxifene—osteoporosis	0.00031	0.000489	CcSEcCtD
Betaxolol—Vomiting—Ibandronate—osteoporosis	0.000309	0.000488	CcSEcCtD
Betaxolol—Tremor—Estradiol—osteoporosis	0.000308	0.000486	CcSEcCtD
Betaxolol—Headache—Raloxifene—osteoporosis	0.000308	0.000486	CcSEcCtD
Betaxolol—Rash—Ibandronate—osteoporosis	0.000307	0.000484	CcSEcCtD
Betaxolol—Dermatitis—Ibandronate—osteoporosis	0.000307	0.000484	CcSEcCtD
Betaxolol—Dyspepsia—Zoledronate—osteoporosis	0.000306	0.000484	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000305	0.000482	CcSEcCtD
Betaxolol—Ill-defined disorder—Estradiol—osteoporosis	0.000305	0.000481	CcSEcCtD
Betaxolol—Headache—Ibandronate—osteoporosis	0.000305	0.000481	CcSEcCtD
Betaxolol—Insomnia—Conjugated Estrogens—osteoporosis	0.000303	0.000479	CcSEcCtD
Betaxolol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000303	0.000478	CcSEcCtD
Betaxolol—Vomiting—Calcitriol—osteoporosis	0.000303	0.000478	CcSEcCtD
Betaxolol—Decreased appetite—Zoledronate—osteoporosis	0.000303	0.000478	CcSEcCtD
Betaxolol—Nausea—Estropipate—osteoporosis	0.000301	0.000476	CcSEcCtD
Betaxolol—Body temperature increased—Pamidronate—osteoporosis	0.000301	0.000476	CcSEcCtD
Betaxolol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000301	0.000475	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000301	0.000474	CcSEcCtD
Betaxolol—Rash—Calcitriol—osteoporosis	0.0003	0.000474	CcSEcCtD
Betaxolol—Fatigue—Zoledronate—osteoporosis	0.0003	0.000474	CcSEcCtD
Betaxolol—Dermatitis—Calcitriol—osteoporosis	0.0003	0.000473	CcSEcCtD
Betaxolol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000299	0.000472	CcSEcCtD
Betaxolol—Headache—Calcitriol—osteoporosis	0.000298	0.000471	CcSEcCtD
Betaxolol—Pain—Zoledronate—osteoporosis	0.000298	0.00047	CcSEcCtD
Betaxolol—Constipation—Zoledronate—osteoporosis	0.000298	0.00047	CcSEcCtD
Betaxolol—Nausea—Alendronate—osteoporosis	0.000297	0.000468	CcSEcCtD
Betaxolol—Malaise—Estradiol—osteoporosis	0.000296	0.000468	CcSEcCtD
Betaxolol—Hypersensitivity—Risedronate—osteoporosis	0.000295	0.000466	CcSEcCtD
Betaxolol—Vertigo—Estradiol—osteoporosis	0.000295	0.000466	CcSEcCtD
Betaxolol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000295	0.000466	CcSEcCtD
Betaxolol—Asthenia—Ethinyl Estradiol—osteoporosis	0.000295	0.000466	CcSEcCtD
Betaxolol—Syncope—Estradiol—osteoporosis	0.000295	0.000465	CcSEcCtD
Betaxolol—Nausea—Raloxifene—osteoporosis	0.000292	0.000461	CcSEcCtD
Betaxolol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000291	0.00046	CcSEcCtD
Betaxolol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000291	0.000459	CcSEcCtD
Betaxolol—Palpitations—Estradiol—osteoporosis	0.000291	0.000458	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000289	0.000457	CcSEcCtD
Betaxolol—Fatigue—Conjugated Estrogens—osteoporosis	0.000289	0.000456	CcSEcCtD
Betaxolol—Nausea—Ibandronate—osteoporosis	0.000289	0.000456	CcSEcCtD
Betaxolol—Loss of consciousness—Estradiol—osteoporosis	0.000289	0.000456	CcSEcCtD
Betaxolol—Asthenia—Risedronate—osteoporosis	0.000288	0.000454	CcSEcCtD
Betaxolol—Feeling abnormal—Zoledronate—osteoporosis	0.000287	0.000453	CcSEcCtD
Betaxolol—Cough—Estradiol—osteoporosis	0.000287	0.000453	CcSEcCtD
Betaxolol—Pain—Conjugated Estrogens—osteoporosis	0.000287	0.000452	CcSEcCtD
Betaxolol—Constipation—Conjugated Estrogens—osteoporosis	0.000287	0.000452	CcSEcCtD
Betaxolol—Pruritus—Risedronate—osteoporosis	0.000284	0.000448	CcSEcCtD
Betaxolol—Nausea—Calcitriol—osteoporosis	0.000283	0.000446	CcSEcCtD
Betaxolol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000281	0.000444	CcSEcCtD
Betaxolol—Hypersensitivity—Pamidronate—osteoporosis	0.000281	0.000443	CcSEcCtD
Betaxolol—Chest pain—Estradiol—osteoporosis	0.00028	0.000442	CcSEcCtD
Betaxolol—Myalgia—Estradiol—osteoporosis	0.00028	0.000442	CcSEcCtD
Betaxolol—Arthralgia—Estradiol—osteoporosis	0.00028	0.000442	CcSEcCtD
Betaxolol—Anxiety—Estradiol—osteoporosis	0.000279	0.00044	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000278	0.000439	CcSEcCtD
Betaxolol—Urticaria—Zoledronate—osteoporosis	0.000277	0.000436	CcSEcCtD
Betaxolol—Discomfort—Estradiol—osteoporosis	0.000277	0.000436	CcSEcCtD
Betaxolol—Body temperature increased—Zoledronate—osteoporosis	0.000275	0.000434	CcSEcCtD
Betaxolol—Diarrhoea—Risedronate—osteoporosis	0.000274	0.000433	CcSEcCtD
Betaxolol—Dry mouth—Estradiol—osteoporosis	0.000274	0.000432	CcSEcCtD
Betaxolol—Asthenia—Pamidronate—osteoporosis	0.000273	0.000432	CcSEcCtD
Betaxolol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000272	0.000429	CcSEcCtD
Betaxolol—Confusional state—Estradiol—osteoporosis	0.000271	0.000427	CcSEcCtD
Betaxolol—Pruritus—Pamidronate—osteoporosis	0.00027	0.000426	CcSEcCtD
Betaxolol—Oedema—Estradiol—osteoporosis	0.000268	0.000423	CcSEcCtD
Betaxolol—Infection—Estradiol—osteoporosis	0.000267	0.000421	CcSEcCtD
Betaxolol—Urticaria—Conjugated Estrogens—osteoporosis	0.000266	0.00042	CcSEcCtD
Betaxolol—Dizziness—Risedronate—osteoporosis	0.000265	0.000418	CcSEcCtD
Betaxolol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000265	0.000418	CcSEcCtD
Betaxolol—Shock—Estradiol—osteoporosis	0.000264	0.000417	CcSEcCtD
Betaxolol—Nervous system disorder—Estradiol—osteoporosis	0.000263	0.000415	CcSEcCtD
Betaxolol—Tachycardia—Estradiol—osteoporosis	0.000262	0.000413	CcSEcCtD
Betaxolol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000261	0.000413	CcSEcCtD
Betaxolol—Diarrhoea—Pamidronate—osteoporosis	0.000261	0.000412	CcSEcCtD
Betaxolol—Skin disorder—Estradiol—osteoporosis	0.000261	0.000411	CcSEcCtD
Betaxolol—Hyperhidrosis—Estradiol—osteoporosis	0.000259	0.000409	CcSEcCtD
Betaxolol—Rash—Ethinyl Estradiol—osteoporosis	0.000259	0.000409	CcSEcCtD
Betaxolol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000259	0.000409	CcSEcCtD
Betaxolol—Headache—Ethinyl Estradiol—osteoporosis	0.000258	0.000407	CcSEcCtD
Betaxolol—Hypersensitivity—Zoledronate—osteoporosis	0.000257	0.000405	CcSEcCtD
Betaxolol—Vomiting—Risedronate—osteoporosis	0.000255	0.000402	CcSEcCtD
Betaxolol—Rash—Risedronate—osteoporosis	0.000253	0.000399	CcSEcCtD
Betaxolol—Dermatitis—Risedronate—osteoporosis	0.000253	0.000399	CcSEcCtD
Betaxolol—Dizziness—Pamidronate—osteoporosis	0.000252	0.000398	CcSEcCtD
Betaxolol—Headache—Risedronate—osteoporosis	0.000251	0.000396	CcSEcCtD
Betaxolol—Asthenia—Zoledronate—osteoporosis	0.00025	0.000394	CcSEcCtD
Betaxolol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000247	0.00039	CcSEcCtD
Betaxolol—Pruritus—Zoledronate—osteoporosis	0.000246	0.000389	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000244	0.000386	CcSEcCtD
Betaxolol—Nausea—Ethinyl Estradiol—osteoporosis	0.000244	0.000385	CcSEcCtD
Betaxolol—Insomnia—Estradiol—osteoporosis	0.000243	0.000383	CcSEcCtD
Betaxolol—Vomiting—Pamidronate—osteoporosis	0.000242	0.000382	CcSEcCtD
Betaxolol—Paraesthesia—Estradiol—osteoporosis	0.000241	0.00038	CcSEcCtD
Betaxolol—Asthenia—Conjugated Estrogens—osteoporosis	0.000241	0.00038	CcSEcCtD
Betaxolol—Rash—Pamidronate—osteoporosis	0.00024	0.000379	CcSEcCtD
Betaxolol—Dermatitis—Pamidronate—osteoporosis	0.00024	0.000379	CcSEcCtD
Betaxolol—Dyspnoea—Estradiol—osteoporosis	0.000239	0.000378	CcSEcCtD
Betaxolol—Headache—Pamidronate—osteoporosis	0.000239	0.000377	CcSEcCtD
Betaxolol—Diarrhoea—Zoledronate—osteoporosis	0.000238	0.000376	CcSEcCtD
Betaxolol—Nausea—Risedronate—osteoporosis	0.000238	0.000376	CcSEcCtD
Betaxolol—Pruritus—Conjugated Estrogens—osteoporosis	0.000237	0.000374	CcSEcCtD
Betaxolol—Dyspepsia—Estradiol—osteoporosis	0.000236	0.000373	CcSEcCtD
Betaxolol—Decreased appetite—Estradiol—osteoporosis	0.000233	0.000368	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000232	0.000366	CcSEcCtD
Betaxolol—Fatigue—Estradiol—osteoporosis	0.000231	0.000365	CcSEcCtD
Betaxolol—Dizziness—Zoledronate—osteoporosis	0.00023	0.000363	CcSEcCtD
Betaxolol—Constipation—Estradiol—osteoporosis	0.000229	0.000362	CcSEcCtD
Betaxolol—Pain—Estradiol—osteoporosis	0.000229	0.000362	CcSEcCtD
Betaxolol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000229	0.000362	CcSEcCtD
Betaxolol—Nausea—Pamidronate—osteoporosis	0.000226	0.000357	CcSEcCtD
Betaxolol—Dizziness—Conjugated Estrogens—osteoporosis	0.000222	0.00035	CcSEcCtD
Betaxolol—Vomiting—Zoledronate—osteoporosis	0.000221	0.000349	CcSEcCtD
Betaxolol—Feeling abnormal—Estradiol—osteoporosis	0.000221	0.000349	CcSEcCtD
Betaxolol—Rash—Zoledronate—osteoporosis	0.00022	0.000346	CcSEcCtD
Betaxolol—Dermatitis—Zoledronate—osteoporosis	0.000219	0.000346	CcSEcCtD
Betaxolol—Headache—Zoledronate—osteoporosis	0.000218	0.000344	CcSEcCtD
Betaxolol—Vomiting—Conjugated Estrogens—osteoporosis	0.000213	0.000336	CcSEcCtD
Betaxolol—Urticaria—Estradiol—osteoporosis	0.000213	0.000336	CcSEcCtD
Betaxolol—Body temperature increased—Estradiol—osteoporosis	0.000212	0.000335	CcSEcCtD
Betaxolol—Rash—Conjugated Estrogens—osteoporosis	0.000211	0.000334	CcSEcCtD
Betaxolol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000211	0.000333	CcSEcCtD
Betaxolol—Headache—Conjugated Estrogens—osteoporosis	0.00021	0.000331	CcSEcCtD
Betaxolol—Nausea—Zoledronate—osteoporosis	0.000207	0.000326	CcSEcCtD
Betaxolol—Nausea—Conjugated Estrogens—osteoporosis	0.000199	0.000314	CcSEcCtD
Betaxolol—Hypersensitivity—Estradiol—osteoporosis	0.000198	0.000312	CcSEcCtD
Betaxolol—Asthenia—Estradiol—osteoporosis	0.000193	0.000304	CcSEcCtD
Betaxolol—Pruritus—Estradiol—osteoporosis	0.00019	0.0003	CcSEcCtD
Betaxolol—Diarrhoea—Estradiol—osteoporosis	0.000184	0.00029	CcSEcCtD
Betaxolol—Dizziness—Estradiol—osteoporosis	0.000177	0.00028	CcSEcCtD
Betaxolol—Vomiting—Estradiol—osteoporosis	0.000171	0.000269	CcSEcCtD
Betaxolol—Rash—Estradiol—osteoporosis	0.000169	0.000267	CcSEcCtD
Betaxolol—Dermatitis—Estradiol—osteoporosis	0.000169	0.000267	CcSEcCtD
Betaxolol—Headache—Estradiol—osteoporosis	0.000168	0.000265	CcSEcCtD
Betaxolol—Nausea—Estradiol—osteoporosis	0.000159	0.000252	CcSEcCtD
